Effects of preoperative chemotherapy on metastatic lymph nodes in esophageal squamous cell carcinoma.

The aim of this study was to evaluate the effect of preoperative chemotherapy on metastatic lymph nodes and on the outcome of patients who underwent esophagectomy for advanced squamous cell carcinoma of the esophagus. Fifty-nine patients with potentially resectable squamous cell carcinoma of the esophagus were studied. Twenty patients (group A) were treated by preoperative chemotherapy with cisplatin, 5-fluorouracil, and leucovorin, followed by surgery. Thirty-nine patients underwent surgery alone (group B). A total of 2591 resected lymph nodes were histologically evaluated for metastasis and the effect of chemotherapy. The metastasis rate in the resected lymph nodes, the number of metastatic lymph nodes, and outcome of the patients were statistically analyzed between groups. In group A, the clinical and pathological response rates were 75% and 75% respectively. The metastasis rate in the resected lymph nodes was significantly higher in group B (P < 0.01). The mean number of metastatic lymph nodes was significantly lower in group A (P < 0.05). Furthermore, the mean number of metastatic lymph nodes was significantly lower in the chemotherapy responders than in non-responders. The survival rate in group A was better than in group B (P = 0.07). Preoperative chemotherapy reduced the number of metastatic lymph nodes and may contribute to improving the outcome of the patients who have undergone esophagectomy for squamous cell carcinoma of the esophagus.

[1]  J. Cooper,et al.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. , 1999, JAMA.

[2]  H. Höfler,et al.  Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma , 1999, Cancer.

[3]  S. Seeber,et al.  Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities , 1999, International journal of cancer.

[4]  J. Ajani,et al.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. , 1998, The New England journal of medicine.

[5]  S. Seeber,et al.  Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  M. Feith,et al.  Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma , 1998, Cancer.

[7]  D. Mcfadden,et al.  p21 expression is increased by irradiation in esophageal squamous cell carcinoma. , 1998, The Journal of surgical research.

[8]  T. Hideshima,et al.  The number of lymph node metastases influences survival in esophageal cancer , 1998, Journal of surgical oncology.

[9]  V. Chiarion-Sileni,et al.  First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up. , 1997, Annals of surgery.

[10]  A. Niendorf,et al.  Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. , 1997, The New England journal of medicine.

[11]  M. Ota,et al.  Neoadjuvant chemotherapy with cisplatinum/5-fluorouracil/low-dose leucovorin for advanced squamous cell carcinoma of the esophagus. , 1997, Seminars in surgical oncology.

[12]  H. Fujita,et al.  Pattern of Recurrence after Extended Radical Esophagectomy with Three-Field Lymph Node Dissection for Squamous Cell Carcinoma in the Thoracic Esophagus , 1997, World Journal of Surgery.

[13]  M. Huang,et al.  Management for patients with advanced T4 epidermoid carcinoma of the esophagus , 1996, Journal of surgical oncology.

[14]  D. Kelsen,et al.  Chemotherapy and combined-modality therapy for esophageal cancer. , 1995, Chest.

[15]  D. Housman,et al.  p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.

[16]  R. Brown,et al.  Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. , 1994, Cancer research.

[17]  J. Peters,et al.  Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography. , 1994, Archives of surgery.

[18]  R. Stuart,et al.  Surgical therapy for squamous-cell carcinoma of the oesophagus , 1994, The Lancet.

[19]  A. Redkar,et al.  Prognosis of operable squamous cell carcinoma of the esophagus. Relationship with clinicopathologic features and DNA ploidy , 1993, Cancer.

[20]  H. Dittler,et al.  Role of Endoscopic Ultrasonography in Esophageal Carcinoma , 1993, Endoscopy.

[21]  P. Schlag.  Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. , 1992, Archives of surgery.

[22]  J. Siewert,et al.  Preoperative staging and risk analysis in esophageal carcinoma. , 1990, Hepato-gastroenterology.

[23]  W. Bleyer,et al.  New vistas for leucovorin in cancer chemotherapy , 1989, Cancer.

[24]  R. Moran.  Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase , 1989 .

[25]  D. Skinner,et al.  Selection of Operation for Esophageal Cancer Based on Staging , 1986, Annals of surgery.

[26]  D. Skinner,et al.  Potentially curable cancer of the esophagus. , 1982, Cancer.

[27]  T. Nishihira,et al.  A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. , 1998, American journal of surgery.

[28]  M. Orringer,et al.  Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.